(S)-4-Benzyl-3-propionyl-2-oxazolidinone-d3
|
- $155 - $2120
- Product name: (S)-4-Benzyl-3-propionyl-2-oxazolidinone-d3
- CAS: 156451-08-0
- MF: C13H15NO3
- MW: 233.27
- EINECS:
- MDL Number:MFCD31562966
- Synonyms:(S)-4-Benzyl-3-propionyl-2-oxazolidinone-d3;(+)-4-Benzyl-3-propionyl-2-oxazolidinone-d3;(4S)-3-(1-Oxopropyl)-4-(phenylMethyl)-2-oxazolidinone-d3;(4S)-4-Benzyl-3-propanoyloxazolidin-2-one-d3;(4S)-4-Benzyl-3-propionyl-1,3-oxazolidin-2-one-d3;(S)-N-Propi
4 prices
Selected condition：
Brand
- Medical Isotopes, Inc.
- TRC
Package
- 50mg
- 500mg
- ManufacturerMedical Isotopes, Inc.
- Product numberD49795
- Product description(S)-4-Benzyl-3-propionyl-2-oxazolidinone-d3
- Packaging50mg
- Price$640
- Updated2021-12-16
- Buy
- ManufacturerMedical Isotopes, Inc.
- Product numberD49795
- Product description(S)-4-Benzyl-3-propionyl-2-oxazolidinone-d3
- Packaging500mg
- Price$2120
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB288652
- Product description(S)-4-Benzyl-3-propionyl-2-oxazolidinone-d3
- Packaging50mg
- Price$155
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB288652
- Product description(S)-4-Benzyl-3-propionyl-2-oxazolidinone-d3
- Packaging500mg
- Price$1230
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Medical Isotopes, Inc. | D49795 | (S)-4-Benzyl-3-propionyl-2-oxazolidinone-d3 | 50mg | $640 | 2021-12-16 | Buy |
| Medical Isotopes, Inc. | D49795 | (S)-4-Benzyl-3-propionyl-2-oxazolidinone-d3 | 500mg | $2120 | 2021-12-16 | Buy |
| TRC | B288652 | (S)-4-Benzyl-3-propionyl-2-oxazolidinone-d3 | 50mg | $155 | 2021-12-16 | Buy |
| TRC | B288652 | (S)-4-Benzyl-3-propionyl-2-oxazolidinone-d3 | 500mg | $1230 | 2021-12-16 | Buy |
Properties
solubility :Chloroform, Dichloromethane, Ethyl Acetate, Methanol
form :Solid
color :Colourless
form :Solid
color :Colourless
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|